Task: Answer the multiple-choice question.
Question: Which drug exhibits a 2.201\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a) Cc1ccc(S(=O)(=O)Nc2cccc(C(=O)NCC(c3ccccc3)N(C)C)c2)cc1F
b) Cc1nn(Cc2ccc(F)cc2Cl)c(C)c1[N+](=O)[O-]
c) CC(C)n1cc(/C(N)=N/O)c(=O)n(Cc2ccccc2)c1=O
Answer: c. CC(C)n1cc(/C(N)=N/O)c(=O)n(Cc2ccccc2)c1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(C)n1cc(/C(N)=N/O)c(=O)n(Cc2ccccc2)c1=O
CC(C)n1cc(/C(N)=N/O)c(=O)n(Cc2ccccc2)c1=O
3-benzyl-N'-hydroxy-2,4-dioxo-1-propan-2-ylpyrimidine-5-carboximidamide